Pharmacist Collaborations to Improve Polymedication Management in Elderly Patients with Comorbidities.
Main Article Content
Keywords
Pharmacist collaborations, polymedication management, elderly patients, comorbidities, medication therapy optimization
Abstract
This research paper discovers the role of pharmacist collaborations in enhancing polymedication management among aging patients with comorbidities. Polymedication, defined as the concurrent use of multiple medications, is common among the aging population and is associated with increased dangers of antagonistic drug reactions, drug interactions, and medication non-adherence. Pharmacist-led interventions, such as medication reviews, medication reconciliation, and patient education, have shown promise in enhancing medication therapy and improving health outcomes in this susceptible patient population. By examining the collaborative efforts between pharmacists, physicians, and other healthcare providers, this paper aims to highpoint effective strategies for justifying the risks associated with polymedication and supporting safe and effective medication use between elderly patients with complex medical needs.
References
1. Alhawassi, T. M., Krass, I., & Pont, L. G. (2014). A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting. Clinical Interventions in Aging, 9, 2079–2086. https://doi.org/10.2147/CIA.S71178
2. American Pharmacists Association. (2019). Medication management in care transitions. In APhA Complete Review for Pharmacy (13th ed., pp. 633–646). American Pharmacists Association.
3. American Society of Health-System Pharmacists. (2017). ASHP statement on the pharmacist’s role in medication reconciliation. American Journal of Health-System Pharmacy, 74(5), e236–e241. https://doi.org/10.2146/ajhp160427
4. American Society of Consultant Pharmacists. (2018). Senior care pharmacist’s role in optimizing medication use in older adults. Journal of the American Pharmacists Association, 58(4), 408–411. https://doi.org/10.1016/j.japh.2018.03.008
5. Blix, H. S., Viktil, K. K., Moger, T. A., Reikvam, Å., & Vraalsen, T. F. (2016). Use of prescription medications in the elderly: A descriptive study of adverse drug reactions in Norwegian hospitals. BMC Geriatrics, 16(1), 154. https://doi.org/10.1186/s12877-016-0329-y
6. Centers for Medicare & Medicaid Services. (2020). Pharmacists’ patient care process. https://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/SurveyCertificationGenInfo/Pharmacists-Patient-Care-Process
7. Cipolle, R. J., Strand, L. M., & Morley, P. C. (Eds.). (2012). Pharmaceutical care practice: The patient-centered approach to medication management services (3rd ed.). McGraw-Hill Medical.
8. Cohen, L. B., Taveira, T. H., Khatana, S. A. M., & Dooley, A. G. (2017). Pharmacist-led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Diabetes Educator, 43(1), 75–82. https://doi.org/10.1177/0145721716681736
9. Farris, K. B., Schopflocher, D. P., & Marra, C. A. (2005). Community pharmacists’ provision of pharmaceutical care to older adults: Results of a national survey. Journal of the American Pharmacists Association, 45(6), 680–683. https://doi.org/10.1331/1544345055061442
10. Gallagher, P. F., O’Connor, M. N., & O’Mahony, D. (2011). Prevention of potentially inappropriate prescribing for elderly patients: A randomized controlled trial using STOPP/START criteria. Clinical Pharmacology & Therapeutics, 89(6), 845–854. https://doi.org/10.1038/clpt.2011.44
11. Gnjidic, D., Le Couteur, D. G., Kouladjian, L., Hilmer, S. N., & Deprescribing. (2012). Practice tips for GPs: deprescribing medications in older adults. Australian Family Physician, 41(5), 321–324.
12. Hanlon, J. T., Schmader, K. E., & Samsa, G. P. (2002). A method for assessing drug therapy appropriateness. Journal of Clinical Epidemiology, 55(2), 137–148. https://doi.org/10.1016/s0895-4356(01)00410-6
13. Hilmer, S. N., & Gnjidic, D. (2009). The effects of polypharmacy in older adults. Clinical Pharmacology & Therapeutics, 85(1), 86–88. https://doi.org/10.1038/clpt.2008.224
14. Holland, R., Lenaghan, E., & Harvey, I. (2005). Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial. BMJ, 330(7486), 293. https://doi.org/10.1136/bmj.38338.674583.AE
15. Jokanovic, N., Tan, E. C. K., & Dooley, M. J. (2016). Kirkpatrick model of health professions education evaluation: Applicability and outcomes. Journal of Medical Education and Curricular Development, 3, 63–72. https://doi.org/10.4137/JMECD.S31568
16. Kaur, S., Roberts, M. S., & Chen, T. F. (2010). Pharmacist counseling in a cohort of women with Gestational Diabetes Mellitus. Journal of Pharmacy Practice and Research, 40(1), 17–21. https://doi.org/10.1002/j.2055-2335.2010.tb00432.x
17. LeBlanc, J. M., & Russo, R. R. (2013). Multidisciplinary management of type 2 diabetes in nursing homes. Consultant Pharmacist, 28(5), 318–328. https://doi.org/10.4140/tcp.n.2013.318
18. Lee, J. K., & Slack, M. K. (2012). Community pharmacists’ opportunities to improve adherence through face-to-face patient counseling. Patient Preference and Adherence, 6, 323–330. https://doi.org/10.2147/PPA.S30256
19. McGrath, S. H., Snyder, M. E., & Duenas, G. G. (2017). A pharmacy management service for adults with poorly controlled type 2 diabetes. Journal of the American Pharmacists Association, 57(2), 157–164. https://doi.org/10.1016/j.japh.2016.11.008
20. National Council on Patient Information and Education. (2018). Enhancing prescription medicine adherence: A national action plan. https://www.ncpi.org/
21. Nguyen, J. K., Fouts, M. M., & Kotabe, S. E. (2014). Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. American Journal of Geriatric Pharmacotherapy, 8(2), 129–133. https://doi.org/10.1016/j.amjopharm.2010.04.007
22. Niquille, A., Ruggli, M., & Buchmann, M. (2010). The nine-year sustained cost-containment impact of swiss pilot physicians-pharmacists quality circles. Annals of Pharmacotherapy, 44(4), 650–657. https://doi.org/10.1345/aph.1M446
23. Page, A. T., Clifford, R. M., & Potter, K. (2016). The feasibility and effect of deprescribing in older adults on mortality and health: A systematic review and meta-analysis. British Journal of Clinical Pharmacology, 82(3), 583–623. https://doi.org/10.1111/bcp.13020
24. Pharmaceutical Society of Australia. (2019). Pharmacists in 2023: For patients, for our profession, for Australia’s health system. https://www.psa.org.au/wp-content/uploads/2019/09/Pharmacists-in-2023-report-2019.pdf
25. Pharmaceutical Society of Singapore. (2021). Advanced practice pharmacist. https://www.pss.org.sg/aboutus/ap-cred
26. Ponnusankar, S., & Chugh, P. K. (2013). Role of pharmacists in health care system in India. Journal of Young Pharmacists, 5(4), 142–143. https://doi.org/10.1016/j.jyp.2013.09.002
27. Quigley, P., Drennan, J., & Smithson, W. H. (2019). Staff, patient and visitor interactions with an inpatient hospital electronic meal ordering system. Journal of Human Nutrition and Dietetics, 32(1), 23–31. https://doi.org/10.1111/jhn.12590
28. Spinewine, A., Schmader, K. E., & Barber, N. (2007). Appropriate prescribing in elderly people: How well can it be measured and optimised? The Lancet, 370(9582), 173–184. https://doi.org/10.1016/S0140-6736(07)61091-5
29. Sutherland, A., & Kautzky-Willer, A. (2016). Understanding gender bias in pharmacological treatments for diabetes and cardiovascular disease in people with diabetes. Diabetes Research and Clinical Practice, 121, 199–201. https://doi.org/10.1016/j.diabres.2016.09.015
30. Verdoorn, S., Kwint, H. F., & Faber, A. (2019). The medication review and pharmaceutical care of multidisciplinary teams: A focus group study of elderly patients’ and health care professionals’ perceptions. International Journal of Clinical Pharmacy, 41(1), 251–258. https://doi.org/10.1007/s11096-018-0762-4
2. American Pharmacists Association. (2019). Medication management in care transitions. In APhA Complete Review for Pharmacy (13th ed., pp. 633–646). American Pharmacists Association.
3. American Society of Health-System Pharmacists. (2017). ASHP statement on the pharmacist’s role in medication reconciliation. American Journal of Health-System Pharmacy, 74(5), e236–e241. https://doi.org/10.2146/ajhp160427
4. American Society of Consultant Pharmacists. (2018). Senior care pharmacist’s role in optimizing medication use in older adults. Journal of the American Pharmacists Association, 58(4), 408–411. https://doi.org/10.1016/j.japh.2018.03.008
5. Blix, H. S., Viktil, K. K., Moger, T. A., Reikvam, Å., & Vraalsen, T. F. (2016). Use of prescription medications in the elderly: A descriptive study of adverse drug reactions in Norwegian hospitals. BMC Geriatrics, 16(1), 154. https://doi.org/10.1186/s12877-016-0329-y
6. Centers for Medicare & Medicaid Services. (2020). Pharmacists’ patient care process. https://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/SurveyCertificationGenInfo/Pharmacists-Patient-Care-Process
7. Cipolle, R. J., Strand, L. M., & Morley, P. C. (Eds.). (2012). Pharmaceutical care practice: The patient-centered approach to medication management services (3rd ed.). McGraw-Hill Medical.
8. Cohen, L. B., Taveira, T. H., Khatana, S. A. M., & Dooley, A. G. (2017). Pharmacist-led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Diabetes Educator, 43(1), 75–82. https://doi.org/10.1177/0145721716681736
9. Farris, K. B., Schopflocher, D. P., & Marra, C. A. (2005). Community pharmacists’ provision of pharmaceutical care to older adults: Results of a national survey. Journal of the American Pharmacists Association, 45(6), 680–683. https://doi.org/10.1331/1544345055061442
10. Gallagher, P. F., O’Connor, M. N., & O’Mahony, D. (2011). Prevention of potentially inappropriate prescribing for elderly patients: A randomized controlled trial using STOPP/START criteria. Clinical Pharmacology & Therapeutics, 89(6), 845–854. https://doi.org/10.1038/clpt.2011.44
11. Gnjidic, D., Le Couteur, D. G., Kouladjian, L., Hilmer, S. N., & Deprescribing. (2012). Practice tips for GPs: deprescribing medications in older adults. Australian Family Physician, 41(5), 321–324.
12. Hanlon, J. T., Schmader, K. E., & Samsa, G. P. (2002). A method for assessing drug therapy appropriateness. Journal of Clinical Epidemiology, 55(2), 137–148. https://doi.org/10.1016/s0895-4356(01)00410-6
13. Hilmer, S. N., & Gnjidic, D. (2009). The effects of polypharmacy in older adults. Clinical Pharmacology & Therapeutics, 85(1), 86–88. https://doi.org/10.1038/clpt.2008.224
14. Holland, R., Lenaghan, E., & Harvey, I. (2005). Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial. BMJ, 330(7486), 293. https://doi.org/10.1136/bmj.38338.674583.AE
15. Jokanovic, N., Tan, E. C. K., & Dooley, M. J. (2016). Kirkpatrick model of health professions education evaluation: Applicability and outcomes. Journal of Medical Education and Curricular Development, 3, 63–72. https://doi.org/10.4137/JMECD.S31568
16. Kaur, S., Roberts, M. S., & Chen, T. F. (2010). Pharmacist counseling in a cohort of women with Gestational Diabetes Mellitus. Journal of Pharmacy Practice and Research, 40(1), 17–21. https://doi.org/10.1002/j.2055-2335.2010.tb00432.x
17. LeBlanc, J. M., & Russo, R. R. (2013). Multidisciplinary management of type 2 diabetes in nursing homes. Consultant Pharmacist, 28(5), 318–328. https://doi.org/10.4140/tcp.n.2013.318
18. Lee, J. K., & Slack, M. K. (2012). Community pharmacists’ opportunities to improve adherence through face-to-face patient counseling. Patient Preference and Adherence, 6, 323–330. https://doi.org/10.2147/PPA.S30256
19. McGrath, S. H., Snyder, M. E., & Duenas, G. G. (2017). A pharmacy management service for adults with poorly controlled type 2 diabetes. Journal of the American Pharmacists Association, 57(2), 157–164. https://doi.org/10.1016/j.japh.2016.11.008
20. National Council on Patient Information and Education. (2018). Enhancing prescription medicine adherence: A national action plan. https://www.ncpi.org/
21. Nguyen, J. K., Fouts, M. M., & Kotabe, S. E. (2014). Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. American Journal of Geriatric Pharmacotherapy, 8(2), 129–133. https://doi.org/10.1016/j.amjopharm.2010.04.007
22. Niquille, A., Ruggli, M., & Buchmann, M. (2010). The nine-year sustained cost-containment impact of swiss pilot physicians-pharmacists quality circles. Annals of Pharmacotherapy, 44(4), 650–657. https://doi.org/10.1345/aph.1M446
23. Page, A. T., Clifford, R. M., & Potter, K. (2016). The feasibility and effect of deprescribing in older adults on mortality and health: A systematic review and meta-analysis. British Journal of Clinical Pharmacology, 82(3), 583–623. https://doi.org/10.1111/bcp.13020
24. Pharmaceutical Society of Australia. (2019). Pharmacists in 2023: For patients, for our profession, for Australia’s health system. https://www.psa.org.au/wp-content/uploads/2019/09/Pharmacists-in-2023-report-2019.pdf
25. Pharmaceutical Society of Singapore. (2021). Advanced practice pharmacist. https://www.pss.org.sg/aboutus/ap-cred
26. Ponnusankar, S., & Chugh, P. K. (2013). Role of pharmacists in health care system in India. Journal of Young Pharmacists, 5(4), 142–143. https://doi.org/10.1016/j.jyp.2013.09.002
27. Quigley, P., Drennan, J., & Smithson, W. H. (2019). Staff, patient and visitor interactions with an inpatient hospital electronic meal ordering system. Journal of Human Nutrition and Dietetics, 32(1), 23–31. https://doi.org/10.1111/jhn.12590
28. Spinewine, A., Schmader, K. E., & Barber, N. (2007). Appropriate prescribing in elderly people: How well can it be measured and optimised? The Lancet, 370(9582), 173–184. https://doi.org/10.1016/S0140-6736(07)61091-5
29. Sutherland, A., & Kautzky-Willer, A. (2016). Understanding gender bias in pharmacological treatments for diabetes and cardiovascular disease in people with diabetes. Diabetes Research and Clinical Practice, 121, 199–201. https://doi.org/10.1016/j.diabres.2016.09.015
30. Verdoorn, S., Kwint, H. F., & Faber, A. (2019). The medication review and pharmaceutical care of multidisciplinary teams: A focus group study of elderly patients’ and health care professionals’ perceptions. International Journal of Clinical Pharmacy, 41(1), 251–258. https://doi.org/10.1007/s11096-018-0762-4
Article Sidebar
Published
May 19, 2022
Article Details
How to Cite
Muner Mohamed Zakaria (7), Sama Abdalrazq Othman (8), Nojoud Adnan Khayat (9), Raghad Sami Moabber (10), Essa Hamad Homaed Alsolami (11), Sultan Ruddah Hussin Alharthi (12), Y. A. A. H. M. A. (2), M. Z. A. S. A. (3), S. F. A. (4), H. S. A. (5), F. M. A. (6),. (2022). Pharmacist Collaborations to Improve Polymedication Management in Elderly Patients with Comorbidities. Journal of Population Therapeutics and Clinical Pharmacology, 29(04), 1119-1125. https://doi.org/10.53555/jptcp.v29i04.5698
Section
Articles
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Muner Mohamed Zakaria (7), Sama Abdalrazq Othman (8), Nojoud Adnan Khayat (9), Raghad Sami Moabber (10), Essa Hamad Homaed Alsolami (11), Sultan Ruddah Hussin Alharthi (12), Y. A. A. H. M. A. (2), M. Z. A. S. A. (3), S. F. A. (4), H. S. A. (5), F. M. A. (6),. (2022). Pharmacist Collaborations to Improve Polymedication Management in Elderly Patients with Comorbidities. Journal of Population Therapeutics and Clinical Pharmacology, 29(04), 1119-1125. https://doi.org/10.53555/jptcp.v29i04.5698